INIS
proteins
100%
drugs
66%
diseases
45%
genes
39%
receptors
39%
ischemia
37%
kinases
36%
reviews
36%
interactions
35%
nervous system diseases
33%
transcription factors
33%
screening
28%
cancer
28%
apoptosis
26%
serine
24%
threonine
24%
design
24%
death
23%
interventions
19%
inflammation
19%
brain
19%
inhibition
18%
applications
18%
levels
18%
dna
17%
molecular dynamics method
17%
molecules
14%
humans
14%
medicines
13%
therapy
13%
in vitro
12%
modeling
12%
ligands
12%
host
11%
mitochondria
11%
toxicity
11%
simulation
10%
necrosis
10%
morphology
9%
control
9%
permeability
9%
abundance
9%
regulations
9%
machine learning
9%
uptake
9%
public health
8%
hemolysis
8%
synthetases
8%
biotechnology
8%
lysis
8%
Biochemistry, Genetics and Molecular Biology
Pharmacophore
31%
Casein Kinase
24%
Binding Site
18%
Cyclophilin
18%
MicroRNA
17%
Transcription Factors
16%
Cell Death
15%
Necroptosis
15%
Influenza A Virus (H1N1)
8%
Hemagglutinin
8%
DNA Binding
8%
Binding Affinity
8%
RIPK3
8%
Network Motif
8%
Gene Network
8%
Genetic Transcription
8%
Melittin
8%
Gene Sequence
8%
Drug Screening
8%
Phytochemical
8%
Maturation
8%
Protein Kinases
8%
Amikacin
8%
Mitochondrial Permeability Transition Pore
8%
Protein Conformation
8%
Evolution
8%
Lymphocyte
8%
Crystallin
8%
Carnosine
8%
Blumea
8%
Telomerase
8%
Computer Simulation
7%
Ciclosporin
6%
Transcriptional Repressor
5%
Amino Acids
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroprotection
17%
Alzheimer's Disease
16%
Disease
12%
Phytochemical
12%
Death Associated Protein Kinase
11%
Cyclophilin D
10%
Parkinson's Disease
10%
Neurologic Disease
9%
Receptor
9%
microRNA
9%
Drug Development
8%
Titanocene Dichloride
8%
Molecular Target
8%
Melittin
8%
Surfactant
8%
Epidermal Growth Factor Receptor Kinase Inhibitor
8%
Copolymer
8%
Synthetase
8%
Amikacin
8%
Epidermal Growth Factor Receptor
8%
Neuroblastoma
8%
Acarbose
8%
Titanocene
8%
Drug Screening
8%
Transcription Factors
8%
Lactoferrin
8%
Mitochondrial Permeability Transition Pore
8%
Casein Kinase
8%
Antithrombocytic Agent
8%
Crystallin
8%
Nanomaterial
8%
Blumea
8%
Interstitial Lung Disease
8%
Network Pharmacology
8%
Brain Ischemia
7%
Ciclosporin
6%
Drug Resistance
5%
Protein P53
5%
Necrosis
5%
Binding Site
5%